Skip to content

EPICS THERAPEUTICS

Active Public limited companyfounded 2018active for 8 yearsRue Adrienne Bolland 47, 6041 CharleroiKBO/BCE: BE 0690.759.071 #5 company by equity in Hainaut, Pharmaceuticals sector

Board

6 directors, 1 in day-to-day management, 1 auditor, no change since 2025
Director and managing director, permanent representative
appointed by deed of 13-11-2024
Director
since 07-05-2025 term until 14-05-2030
listed in the 2025 annual accounts, filed on 23-06-2026
Director, permanent representative
current term since 07-05-2025 term until 14-05-2030
listed in the 2025 annual accounts, filed on 23-06-2026
Director, permanent representative
current term since 07-05-2025 term until 14-05-2030
also on the board of 2 other companies
listed in the 2025 annual accounts, filed on 23-06-2026
Director
since 07-05-2025 term until 14-05-2030
listed in the 2025 annual accounts, filed on 23-06-2026
Director, permanent representative
current term since 07-05-2025 term until 14-05-2030
also on the board of 241 other companies
listed in the 2025 annual accounts, filed on 23-06-2026
23 other companies bankrupt
Statutory auditor
appointed by deed of 22-12-2021
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Elle est en outre valablement engagée par des mandataires spéciaux dans les limites de leurs mandats.”
deed of 16-07-2024
Permanent representatives 4
Permanent representative, for
appointed by deed of 04-03-2019
Permanent representative, for
appointed by deed of 16-07-2024
Permanent representative, for
appointed by deed of 16-07-2024
Permanent representative, for
appointed by deed of 13-11-2024

Office holders in the KBO →

Mandates through the years

7 names, the dashed line is today

Director

Director

Director

Director, Managing director

Director

Director

Statutory auditor
LeadershipBoardRest of the term
Mandates as a list
    • Director, appointed by deed of 23-03-2018, still in office
    • Director, from 11-05-2023 to date
    • Director, appointed by deed of 16-07-2024, still in office
    • Director, appointed by deed of 13-11-2024, still in office
    • Managing director, appointed by deed of 13-11-2024, still in office
    • Director, from 07-05-2025 to date
    • Director, from 07-05-2025 to date
    • Statutory auditor, appointed by deed of 22-12-2021, still in office
With Starter you also see 12 former office holders in the mandate history. See the plans →

Control

Shareholder
Equity €59.5m
Loss €5.3m in 2025 (loss €18.7m in 2024)
Checked score
24.35%
This company
EPICS THERAPEUTICS
Equity €9.1m
Loss €5.8m in 2025

and 5 other shareholders

Capital

Capital
€350,588.58
Shares
711,709
Contribution per share
€0.49
Equity per share
€12.80 in 2025
Source
deed of 04-08-2026

Owners through the years

as the annual accounts name them
24.35%
14.33%
12.77%
6.33%
4.46%
9.31% until 2024
14.79% until 2022
20.9% until 2018
Owners as a list
    • 2018: 19.92%
    • 2019: 24.3%
    • 2020: 20.13%
    • 2021: 20.73%
    • 2022 to 2023: 22.87%
    • 2024: 23.59%
    • 2025: 24.35%
    • 2023: 14.79%
    • 2024: 14.57%
    • 2025: 14.33%
    • 2019: 13.61%
    • 2020: 12.85%
    • 2022: 13.39%
    • 2025: 12.77%
    • 2023: 5.48%
    • 2024: 5.58%
    • 2025: 6.33%
    • 2019: 3.32%
    • 2020 to 2021: 4.15%
    • 2022: 8.54%
    • 2023: 4.38%
    • 2024 to 2025: 4.46%
    • 2019 to 2020: 4.75%
    • 2021: 9.25%
    • 2022 to 2024: 9.31%
    • 2019: 14.05%
    • 2020 to 2021: 14.06%
    • 2022: 14.79%
    • 2018: 20.9%

Source: lists of holdings in the owners' accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 14-02-2020 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
7 directors
Term of at most 6 years
deed of 16-07-2024 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Actionnaire Décisif
12.5-12.6, mêmes termes et conditions prévues dans Notification de Transfert
deed of 16-07-2024 (in French)
Financial instrumentThe company can also issue securities other than shares, such as bonds or warrants.
Bad Leaver, exerçables ou non
Conseil ajuste Prix d’Exercice et/ou nombre d’Actions si ratio nombre/valeur modifié, options sur actions
deed of 03-07-2025 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Tuesday of May at 10:00
deed of 16-07-2024 (in French)

Shareholders

6 owners

Owners 6

  • Equity €59.5m Loss of €5.3m in 2025 (loss of €18.7m in 2024) Checked score
    Sourceaccounts 2025
    24.35%
  • was absorbed by on 09-01-2023.
    Until then, held 14.79% of the shares here.
    Equity €4.98bn Profit of €151.2m in 2025 (profit of €279.8m in 2024) Checked score
    Sourceaccounts 2025accounts 2022
    14.33%
  • Equity €11.45bn Profit of €290.9m in 2025 (profit of €315.2m in 2024) Checked score
    Sourceaccounts 2025
    12.77%
  • Equity €4.7m Loss of €2,306 in 2025 (loss of €13,561 in 2024) Checked score
    Sourceaccounts 2025
    8.68%+ 0% via subsidiaries
  • Equity €124.0m Loss of €1.8m in 2025 (profit of €2.3m in 2024)
    Sourceaccounts 2025
    6.33%
  • Equity €12.9m Profit of €3.0m in 2025 (profit of €3.1m in 2024) Checked score
    Sourceaccounts 30-06-2025
    4.46%

Capital transactions

Shareholders according to the deeds
After 2 capital increases deed of 03-07-2025 ↗
  • 25,909 shares
  • 11,584 shares
  • 9,759 shares
  • 9,617 shares
  • 6,081 shares
  • 1,783 shares
  • 4,858 shares
  • 5,657 shares
  • 71 shares
  • 4,526 shares
  • 1,783 shares
  • 1,047 shares
  • 1,047 shares
  • 2,973 shares
  • 865 shares
  • 396 shares
  • 242 shares
  • 194 shares
  • 194 shares
  • 582 shares
  • 388 shares
  • 194 shares
  • 194 shares
  • 194 shares
  • 194 shares
  • 194 shares
  • 158 shares
  • 158 shares
  • 85 shares
At incorporation deed of 22-02-2018 ↗
  • founder
  • founder
  • founder
Capital over time
  1. 04-08-2026 Capital stated in the deed · €350,588.58 · 711,709 shares
  2. 07-04-2026 Capital increase of €69,379 · 69,379 new shares · in cash
  3. 03-07-2025 Capital increase of €89,686 · 89,686 new shares · in cash
  4. 14-08-2024 Capital reduction of €340,511.59 · to €191,315.41 · to absorb losses
  5. 16-07-2024 Capital increase of €64,062 · 64,062 new shares · in cash
  6. 28-04-2022 Capital increase of €121,590 · 121,590 new shares · in cash
  7. 01-03-2021 Capital increase of €45,466 · 45,466 new shares · in cash
  8. 01-03-2021 Capital increase · 12,125 new shares
Show 6 older capital entries
  1. 14-02-2020 Capital increase of €75,781 · 75,781 new shares · in cash
  2. 04-03-2019 Capital increase of €48,512 · 48,512 new shares · virements
  3. 04-03-2019 Capital increase of €60,638 · 60,638 new shares · virements
  4. 05-06-2018 Capital increase of €8,152 · to €115,778 · 8,152 new shares, 7% of the 115,778 shares after the increase · “virements à un compte spécial ouvert au nom de la société”
  5. 23-03-2018 Capital increase of €46,126 · to €107,626 · 46,126 new shares, 42.9% of the 107,626 shares after the increase · virements compte spécial nom société
  6. 22-02-2018 Incorporation · €61,500 · 61,500 shares

The directors' other companies

1 current director with another company that went bankrupt, was dissolved or struck off

23 other companies of this director went bankrupt (2012, 2013, 2017, 2019, 2021, 2024, 2025, 2026).

  • bankruptcy on 08-07-2026appointed in 2024, in office until the bankruptcy
  • bankruptcy on 30-04-2026appointed in 2024, in office until the bankruptcy
  • bankruptcy on 24-04-2026appointed in 2025, in office until the bankruptcy
  • bankruptcy on 24-04-2026appointed in 2024, in office until the bankruptcy
  • bankruptcy on 26-03-2026appointed in 2022, in office until the bankruptcy
  • bankruptcy on 12-09-2025appointed in 2023, in office until the bankruptcy
  • bankruptcy on 11-09-2025appointed in 2024, in office until the bankruptcy
  • bankruptcy on 07-08-2025appointed in 2021, in office until the bankruptcy
  • bankruptcy on 02-06-2025appointed in 2021, in office until the bankruptcy
  • bankruptcy on 30-04-2025appointed in 2018, in office until the bankruptcy
  • bankruptcy on 24-10-2024appointed in 2016, in office until the bankruptcy
  • bankruptcy on 04-07-2024appointed in 2018, in office until the bankruptcy
  • bankruptcy on 16-05-2024appointed in 2021, in office until the bankruptcy
  • bankruptcy on 29-01-2024
  • bankruptcy on 25-01-2021appointed in 2010, in office until the bankruptcy
  • bankruptcy on 25-11-2019appointed in 2017, in office until the bankruptcy
  • bankruptcy on 01-06-2017appointed in 2010, in office until the bankruptcy
  • bankruptcy on 18-05-2017appointed in 2010, in office until the bankruptcy
  • bankruptcy on 06-12-2013appointed in 2011, in office until the bankruptcy
  • bankruptcy on 07-05-2013appointed in 2009, in office until the bankruptcy
  • bankruptcy on 06-02-2012appointed in 2010, in office until the bankruptcy
  • bankruptcy on 01-02-2012appointed in 2009, in office until the bankruptcy
  • bankruptcy according to the KBO registerappointed in 2025, still in office

Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.

Next steps